Author: zakaria
-
Amendment of the TRIPS Agreement
WTO members on 6 December 2005 approved changes to the WTO’s intellectual property (TRIPS) agreement in order to make permanent a decision on patents and public health originally adopted in 2003. This was formally built into the TRIPS Agreement after acceptance of the Protocol amending the TRIPS Agreement by two thirds of the WTO’s members.…
-
Youth Toolkit for the High Level Meeting on HIV/AIDS 2016
The youth toolkit for the High Level Meeting on HIV/AIDS (HLM) 2016 is developed by the PACT, a global coalition of youth organizations working collaboratively in the HIV response towards ensuring the health, well-being and human rights of all young people. The toolkit provides information about the HLM including what happens before, during and after…
-
Morocco: Creation of a collective for t the right to health in the framework of the negotiations of the EU ALECA
At a time when the Kingdom of Morocco and the European Union are preparing to resume negotiations on the “comprehensive and thorough free trade agreement” (FTAA), Moroccan civil society unites to bell Alarm about ALECA’s danger of access to generics in our country. A collective for the preservation of the right to health in Morocco in…
-
African Treatment Advocates Call on ViiV Healthcare to Unlock Access to Dolutegravir for North Africa Now
Harare, December 1st, 2015 Today, at the International Conference on AIDS and STIs in Africa (ICASA), treatment advocates and activists from all over Africa united to urge ViiV Healthcare to allow affordable access to an essential drug in four North African countries. A voluntary license from Viiv Healthcare will enable all other countries in Africa…
-
Building Capacity on Intellectual Property, Free Trade Agreement and Access to Medicines Workshop
ATL MST – ITPC MENA WORKSHOP TUNISIA 16, 17 & 18 NOVEMBER 2015 One of the most pressing issues in the 21st century is the lack of availability of essential medicines to poor patients in underdeveloped and developing countries. The problem is attributed to the existing Intellectual Property Rights (IPR) regimes, which were not aligned…
-
Launch of Moroccan Generic Sofosbuvir: A Victory for the Wide-spread Use HCV Treatment in Morocco
According to the Ministry of Health, 625,000 people are infected by HCV, 1.6% of the general population of Morocco. Of those infected, 267,000 people have active chronic infection requiring treatment. Until recently, the management of HCV infection has been hampered by inadequate and costly treatments. The standard treatment involved a combination of pegylated interferon and…
-
Treatment Advocates Denounce Gilead’s Embargo against Thousands of Tunisians Suffering from HCV Infection
The Tunisian Association of Fight against STDs and AIDS (ATL Tunis) and the International Treatment Preparedness Coalition in MENA Region (ITPC-MENA) denounce the refusal of Gilead Sciences to make their drug against the Hepatitis C Virus (HCV), sofosbuvir, available to Tunisian patients. “For months, thousands of patients have been desperately waiting for access to sofosbuvir.…
-
The first Middle East and North Africa Community Advisory Board (MENA-CAB)
Casablanca, Morocco, 28 June-01 July 2014 Despite the fact that HIV prevalence in the countries of the Middle East and North Africa is believed to be low at least among the General Population, the rate of increase of new cases since 2001 makes this region home to one of the most fastest-growing epidemic in the…
-
GENERATION OF CHANGE: Portraits of HIV & AIDS Activists from MENA
The Middle East/North Africa (MENA) region is in turmoil. The trajectory and consequences of the current political, social and economic transformations rippling across the region will become clear in the years ahead. Meanwhile, the region is also experiencing one of the fastest-growing HIV epidemics in the world. In this context of change, a new generation…